Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig
Open Access
- 24 February 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (14) , 1187-1192
- https://doi.org/10.1016/0024-3205(95)00057-d
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treatment of opioid-induced constipation with oral naloxone: A pilot studyClinical Pharmacology & Therapeutics, 1992
- Quantitative and pharmacokinetic analysis of naloxone in plasma using high-performance liquid chromatography with electrochemical detection and solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Stereospecific inhibition of gastrointestinal transit by κ opioid agonists in miceEuropean Journal of Pharmacology, 1988
- Role of opiate receptors in the regulation of colonic transitGastroenterology, 1988
- Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pigLife Sciences, 1988
- Oral naloxone antagonizes loperamide-induced delay of orocecal transitDigestive Diseases and Sciences, 1987
- Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.Gut, 1985
- Morphine tissue levels and reduction of gastrointestinal transit in ratsGastroenterology, 1983
- NALOXONE, A SPECIFIC OPIOID ANTAGONIST, REVERSES CHRONIC IDIOPATHIC CONSTIPATIONThe Lancet, 1983
- Absorption and Distribution of Naloxone in Rats after Oral and Intravenous AdministrationJournal of Pharmaceutical Sciences, 1973